Overview

Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of a new formulation of Myfortic in combination with tacrolimus and thymoglobulin.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Novartis
Treatments:
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus